Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases

被引：0
|
作者：
Kawazoe, Mai [1 ]
Nishio, Junko [1 ,2 ]
Hirose, Wataru [3 ]
Furukawa, Karin [1 ]
Nanki, Toshihiro [1 ]
机构：
[1] Toho Univ, Sch Med, Dept Internal Med, Div Rheumatol, 6-11-1 Omori Nishi, Ota Ku, Tokyo 1438541, Japan
[2] Toho Univ, Sch Med, Dept Immunopathol & Immunoregulat, Tokyo, Japan
[3] Hirose Clin Rheumatol, Saitama, Japan
来源：
EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2023年 / 115卷
关键词：
VACCINATION; AUTOIMMUNE;
D O I：
10.1016/j.ejim.2023.06.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：137 / 139
页数：3
相关论文
共 50 条
  • [31] Immunogenicity and safety of SARS-CoV-2 mRNA vaccine in patients with nephrotic syndrome receiving immunosuppressive agents
    Kamei, Koichi
    Ogura, Masao
    Sato, Mai
    Nishi, Kentaro
    Shoji, Kensuke
    Funaki, Takanori
    Ogimi, Chikara
    Ito, Shuichi
    PEDIATRIC NEPHROLOGY, 2023, 38 (04) : 1099 - 1106
  • [32] Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases
    Boyarsky, Brian J.
    Ruddy, Jake A.
    Connolly, Caoilfhionn M.
    Ou, Michael T.
    Werbel, William A.
    Garonzik-Wang, Jacqueline M.
    Segev, Dorry L.
    Paik, Julie J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (08) : 1098 - 1099
  • [33] SAFETY OF SARS-COV-2 VACCINES IN PATIENTS WITH RHEUMATIC DISEASES: DATA FROM THE NATIONAL REGISTRY SAR-COVAC FROM ARGENTINA
    Cosatti, M.
    D'Angelo, M. E.
    Petkovic, I. E.
    Kogan, N.
    Pereira, D. A.
    Tissera, Y.
    Toledo, M. V.
    Alonso, C. G.
    Garcia, L.
    Severina, M.
    Rosemffet, M.
    Bertoli, A.
    Delavega, M.
    Cosentino, V.
    Maldonado Ficco, H.
    Calle Montoro, C.
    De la Vega Fernandez, S. S.
    Berbotto, G.
    Rollano Perasso, A.
    Gomez Vara, A. B.
    Landi, M.
    Velozo, E.
    Sattler, M. E.
    Perrotat, L.
    Ezquer, R. A.
    Flores Trejo, J.
    Farfan, P.
    Rojas Tessel, R.
    Carrizo Abarza, V.
    Bande, J. M.
    Hernandez, B.
    Papagno, M. J.
    Rodriguez, L. A.
    Martin Koller, V.
    Montoya, F.
    Kreimer, J.
    Luna, P. C.
    Echeverria, C.
    Virasoro, B. M.
    Roberts, K.
    Isnardi, C. A.
    Schneeberger, E. E.
    Pons-Estel, G.
    Pisoni, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 929 - 929
  • [34] ADVERSE EFFECTS OF IVERMECTIN IN SARS-COV-2 PATIENTS
    Poveda Paredes, Francisco Xavier
    Toctaquiza Cumbicos, Kristten Jhamilet
    Goyes Baca, Maria Jose
    REVISTA UNIVERSIDAD Y SOCIEDAD, 2022, 14 : 479 - 487
  • [35] Recommendations on SARS-CoV-2 vaccination in adult patients with rheumatic diseases
    Shen, Min
    Dong, Lingli
    Li, Mengtao
    Zhao, Yan
    Zeng, Xiaofeng
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2021, 2 (04): : 213 - 216
  • [36] Impact of SARS-CoV-2 variants on mRNA vaccines
    Venkatesan, Priya
    LANCET MICROBE, 2021, 2 (09): : E428 - E428
  • [37] Risk factors for SARS-CoV-2 infection in patients with rheumatic diseases
    Snarska, Weronika
    Jurkowska, Zuzanna
    Bobrowska-Snarska, Danuta
    Brzosko, Marek
    Przepiera-Bedzak, Hanna
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (12):
  • [38] SAFETY OF SARS - COV-2 VACCINES IN PATIENTS WITH AUTOIMMUNE DISEASES
    Monov, S.
    Shumnalieva, R.
    Monova, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1686 - 1687
  • [39] HUMORAL AND CELLULAR IMMUNOGENICITY INDUCED BY THIRD BOOSTER OF SARS-COV-2 VACCINES IN PATIENTS WITH RHEUMATIC MUSCULOSKELETAL DISEASES
    Kondo, Y.
    Takeshita, M.
    Saito, S.
    Kikuchi, J.
    Hanaoka, H.
    Suzuki, K.
    Kaneko, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1869 - 1869
  • [40] Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases
    Cozzani, Emanuele
    Gasparini, Giulia
    Sticchi, Laura
    Russo, Roberto
    Icardi, Giancarlo
    Parodi, Aurora
    EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (03) : 415 - 417
12345